PEA-15 Mediates Cytoplasmic Sequestration of ERK MAP Kinase

Developmental Cell

Volumn 1, Issue 2, 2001, Pages 239-250

  Formstecher, Etienne ^a   Ramos, Joe W ^b,e   Fauquet, Mireille ^a   Calderwood, David A ^b   Hsieh, Jyh Cheng ^b   Canton, Brigitte ^a   Nguyen, Xuan Thao ^b   Barnier, Jean Vianney ^d   Camonis, Jacques ^c   Ginsberg, Mark H ^b   Chneiweiss, Hervé ^a,e  

^a l'alimentation et l'Environnement   (France)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c INSERM   (France)

^d CNRS   (France)

^e RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GREEN FLUORESCENT PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEA15 PROTEIN, MOUSE; PHOSPHOPROTEIN; PHOTOPROTEIN;

ACTIVE TRANSPORT; AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BIOLOGICAL MODEL; CELL DIVISION; CELL NUCLEUS; CELL STRAIN 3T3; CELL SURVIVAL; CHO CELL; CYTOPLASM; DOSE RESPONSE; FLUORESCENCE MICROSCOPY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; HAMSTER; IMMUNOHISTOCHEMISTRY; METABOLISM; MOLECULAR GENETICS; MOUSE; MUTATION; NORTHERN BLOTTING; PHYSIOLOGY; PROTEIN BINDING; SEQUENCE HOMOLOGY; SERODIAGNOSIS; SIGNAL TRANSDUCTION; TIME; TWO HYBRID SYSTEM;

3T3 CELLS; ACTIVE TRANSPORT, CELL NUCLEUS; AMINO ACID SEQUENCE; ANIMALS; BLOTTING, NORTHERN; CELL DIVISION; CELL NUCLEUS; CELL SURVIVAL; CHO CELLS; CRICETINAE; CYTOPLASM; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, DRUG; GREEN FLUORESCENT PROTEINS; IMMUNOHISTOCHEMISTRY; LUMINESCENT PROTEINS; MAP KINASE SIGNALING SYSTEM; MICE; MICROSCOPY, FLUORESCENCE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUTATION; PHOSPHOPROTEINS; PRECIPITIN TESTS; PROTEIN BINDING; SEQUENCE HOMOLOGY, AMINO ACID; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 18044405015     PISSN: 15345807     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1534-5807(01)00035-1     Document Type: Article

References (42)

1. Adachi, M., Fukuda, M., and Nishida, E. (2000). Nuclear export of MAP kinase (ERK) involves a MAP kinase kinase (MEK)-dependent active transport mechanism. J. Cell. Biol. 148, 849-856.
2. Araujo, H., Danziger, N., Cordier, J., Glowinski, J., and Chneiweiss, H. (1993). Characterization of PEA-15, a major substrate for protein kinase C in astrocytes. J. Biol. Chem. 268, 5911-5920.
3. Ashkenazi, A., and Dixit, V.M. (1998). Death receptors: signaling and modulation. Science 281, 1305-1308.
4. Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A., and Struhl, K. (1992). Short Protocols in Molecular Biology (New York: Greene and Wiley).
5. Bera, T.K., Guzman, R.C., Miyamoto, S., Panda, D.K., Sasaki, M., Hanyu, K., Enami, J., and Nandi, S. (1994). Identification of a mammary transforming gene (MAT1) associated with mouse mammary carcinogenesis. Proc. Natl. Acad. Sci. USA 91, 9789-9793.
6. Breeden, L., and Nasmyth, K. (1985). Regulation of the yeast HO gene. Cold Spring Harb. Symp. Quant. Biol. 50, 643-650.
7. Brunet, A., Roux, D., Lenormand, P., Dowd, S., Keyse, S., and Pouyssegur, J. (1999). Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J. 18, 664-674.
8. Camps, M., Nichols, A., Gillieron, C., Antonsson, B., Muda, M., Chabert, C., Boschert, U., and Arkinstall, S. (1998). Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. Science 280, 1262-1265.
9. Chabre, O., Cornillon, F., Bottari, S.P., Chambaz, E.M., and Vilgrain, I. (1995). Hormonal regulation of mitogen-activated protein kinase activity in bovine adrenocortical cells: cross-talk between phosphoinositides, adenosine 3′,5′-monophosphate, and tyrosine kinase receptor pathways. Endocrinology 136, 956-964.
10. Cobb, M.H. (1999). MAP kinase pathways. Prog. Biophys. Mol. Biol. 71, 479-500.
11. Condorelli, G., Vigliotta, G., lavarone, C., Caruso, M., Tocchetti, C.G., Andreozzi, F., Cafieri, A., Tecce, M.F., Formisano, P., Beguinot, L., and Beguinot, F. (1998). PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus. EMBO J. 17, 3858-3866.
12. Condorelli, G., Vigliotta, G., Cafieri, A., Trencia, A., Andalo, P., Oriente, F., Miele, C., Caruso, M., Formisano, P., and Beguinot, F. (1999). PED/PEA-15: an anti-apoptotic molecule that regulates FAS/ TNFR1-induced apoptosis. Oncogene 18, 4409-4415.
13. Danziger, N., Yokoyama, M., Jay, T., Cordier, J., Glowinski, J., and Chneiweiss, H. (1995). Cellular expression, developmental regulation, and phylogenic conservation of PEA-15, the astrocytic major phosphoprotein and protein kinase C substrate. J. Neurochem. 64, 1016-1025.
14. Estelles, A., Yokoyama, M., Nothias, F., Vincent, J.D., Glowinski, J., Vernier, P., and Chneiweiss, H. (1996). The major astrocytic phosphoprotein PEA-15 is encoded by two mRNAs conserved on their full length in mouse and human. J. Biol. Chem. 271, 14800-14806.
15. Fornerod, M., Ohno, M., Yoshida, M., and Mattaj, I.W. (1997). CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 90, 1051-1060.
16. Fukuda, M., Asano, S., Nakamura, T., Adachi, M., Yoshida, M., Yanagida, M., and Nishida, E. (1997). CRM1 is responsible for intracellular transport mediated by the nuclear export signal. Nature 390, 308-311.
17. Henderson, B.R., and Eleftheriou, A. (2000). A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals. Exp. Cell Res. 256, 213-224.
18. Hochholdinger, F., Baier, G., Nogalo, A., Bauer, B., Grunicke, H.H., and Uberall, F. (1999). Novel membrane-targeted ERK1 and ERK2 chimeras which act as dominant negative, isotype-specific mitogen-activated protein kinase inhibitors of Ras-Raf-mediated transcriptional activation of cFos in NIH 3T3 cells. Mol. Cell. Biol. 19, 8052-8065.
19. Hughes, P.E., Renshaw, M.W., Pfaff, M., Forsyth, J., Keivens, V.M., Schwartz, M.A., and Ginsberg, M.H. (1997). Suppression of integrin activation: a novel function of a Ras/Raf-initiated MAP kinase pathway. Cell 88, 521-530.
20. Keyse, S.M. (2000). Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr. Opin. Cell Biol. 12, 186-192.
21. Khoo, S., and Cobb, M.H. (1997). Activation of mitogen-activating protein kinase by glucose is not required for insulin secretion. Proc. Natl. Acad. Sci. USA 94, 5599-5604.
22. Kitsberg, D., Formstecher, E., Fauquet, M., Kubes, M., Cordier, J., Canton, B., Pan, G., Rolli, M., Glowinski, J., and Chneiweiss, H. (1999). Knock-out of the neural death-effector-domain protein PEA-15 demonstrates that its expression protects astrocytes from TNFα-induced apoptosis. J. Neurosci. 19, 8244-8251.
23. Kubes, M., Cordier, J., Glowinski, J., Girault, J.A., and Chneiweiss, H. (1998). Endothelin induces a calcium-dependent phosphorylation of PEA-15 in intact astrocytes: identification of Ser104 and Ser116 phosphorylated, respectively, by protein kinase C and calcium/calmodulin kinase II in vitro. J. Neurochem. 71, 1307-1314.
24. Kudo, N., Wolff, B., Sekimoto, T., Schreiner, E.P., Yoneda, Y., Yanagida, M., Horinouchi, S., and Yoshida, M. (1998). Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp. Cell Res. 242, 540-547.
25. Lewis, T.S., Shapiro, P.S., and Ahn, N.G. (1998). Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74, 49-139.
26. Muda, M., Boschert, U., Dickinson, R., Martinou, J.C., Martinou, I., Camps, M., Schlegel, W., and Arkinstall, S. (1996). MKP-3, a novel cytosolic protein-tyrosine phosphatase that exemplifies a new class of mitogen-activated protein kinase phosphatase. J. Biol. Chem. 271, 4319-4326.
27. Pebay, A., Torrens, Y., Toutant, M., Cordier, J., Glowinski, J., and Tence, M. (1999). Pleiotropic effects of lysophosphatidic acid on striatal astrocytes. Glia 28, 25-33.
28. Ramos, J.W., Kojima, T.K., Hughes, P.E., Fenczik, C.A., and Ginsberg, M.H. (1998). The death effector domain of PEA-15 is involved in its regulation of integrin activation. J. Biol. Chem. 273, 33897-33900.
29. Ramos, J.W., Hughes, P.E., Renshaw, M.W., Schwartz, M.A., Formstecher, E., Chneiweiss, H., and Ginsberg, M.H. (2000). Death effector domain protein PEA-15 potentiates ras activation of extracellular signal receptor-activated kinase by an adhesion-independent mechanism. Mol. Biol. Cell 11, 2863-2872.
30. Robinson, M.J., and Cobb, M.H. (1997). Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 9, 180-186.
31. Robinson, M.J., Stippec, S.A., Goldsmith, E., White, M.A., and Cobb, M.H. (1998). A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation. Curr. Biol. 8, 1141-1150.
32. Schaeffer, H.J., and Weber, M.J. (1999). Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol. 19, 2435-2444.
33. Schaeffer, H.J., Catling, A.D., Eblen, S.T., Collier, L.S., Krauss, A., and Weber, M.J. (1998). MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. Science 281, 1668-1671.
34. Schwartz, M.A., Schaller, M.D., and Ginsberg, M.H. (1995). Integrins: emerging paradigms of signal transduction. Annu. Rev. Cell Dev. Biol. 11, 549-599.
35. Shafit-Zagardo, B., and Kalcheva, N. (1998). Making sense of the multiple MAP-2 transcripts and their role in the neuron. Mol. Neurobiol. 16, 149-162.
36. Songyang, Z., Lu, K.P., Kwon, Y.T., Tsai, L.H., Filhol, O., Cochet, C., Brickey, D.A., Soderling, T.R., Bartleson, C., Graves, D.J., et al. (1996). A structural basis for substrate specificities of protein Ser/ Thr kinases: primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1. Mol. Cell. Biol. 16, 6486-6493.
37. Sperling, R., Sperling, J., Levine, A.D., Spann, P., Stark, G.R., and Kornberg, R.D. (1985). Abundant nuclear ribonucleoprotein form of CAD RNA. Mol. Cell. Biol. 5, 569-575.
38. Van Aelst, L., Barr, M., Marcus, S., Polverino, A., and Wigler, M. (1993). Complex formation between RAS and RAF and other protein kinases. Proc. Natl. Acad. Sci. USA 90, 6213-6217.
39. Vojtek, A.B., Hollenberg, S.M., and Cooper, J.A. (1993). Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 74, 205-214.
40. Waskiewicz, A.J., and Cooper, J.A. (1995). Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast. Curr. Opin. Cell Biol. 7, 798-805.
41. Wolff, B., Sanglier, J.J., and Wang, Y. (1997). Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA. Chem. Biol. 4, 139-147.
42. Yang, S.H., Whitmarsh, A.J., Davis, R.J., and Sharrocks, A.D. (1998). Differential targeting of MAP kinases to the ETS-domain transcription factor Elk-1. EMBO J. 17, 1740-1749.